01/04/2017 - 9:35am

VR. AR. AI… Oh my. In this report, DSN outlines big trends, predictions and critical issues that will make the news in 2017 and beyond.

01/03/2017 - 1:36pm
Forbes is reporting that the Food and Drug Administration’s approval of 22 new drugs in 2016 (down from 51 in 2015) could have big implications for the future of innovation in the pharmaceutical space. The report notes that research spending is growing, but there are practical difficulties to translate innovation into products as R&D returns decline  — and the report suggests overcoming that difficulty could mean rethinking a lot. (Forbes)
 
01/03/2017 - 12:54pm

Lupin in the last week of 2016 received tentative approval for its generics of Benicar tablets, Giazo tablets and Livalo tablets. 

01/03/2017 - 12:05pm

The Food and Drug Administration approved three generics from New Jersey-based specialty generics company Teligent on the last day of 2016, the company announced Tuesday.

01/03/2017 - 11:36am

The company on Thursday announced the launch of its generics of Concerta extended-release tablets, Zovia tablets and Cerebyx injection. 

12/28/2016 - 1:45pm

FMI report reveals overall dietary supplements market will grow by more than 7% on a CAGR basis. 

12/28/2016 - 12:05pm

Health care spending now comprises more than one-sixth of the U.S. economy.

12/28/2016 - 11:14am

Any pharmacy can attend event, regardless of which wholesaler of buying group they belong.

12/27/2016 - 12:46pm

Novo Nordisk accused of issuing marketing materials asking patients and doctors to switch from Sanofi’s Lantus and Toujeo drugs to Tresiba, because the Sanofi drugs will be “blocked” by CVS Caremark in January.